Raltegravir-d3(potassium salt) structure
|
Common Name | Raltegravir-d3(potassium salt) | ||
|---|---|---|---|---|
| CAS Number | 1246816-98-7 | Molecular Weight | 485.525 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H17D3FKN6O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | Potassium 4-[(4-fluorobenzyl)carbamoyl]-1-(2H3)methyl-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}-2-propanyl)-6-oxo-1,6-dihydro-5-pyrimidinolate |
|---|---|
| Synonym | More Synonyms |
| Description |
|---|
| Molecular Formula | C20H17D3FKN6O5 |
|---|---|
| Molecular Weight | 485.525 |
| Exact Mass | 485.130463 |
| InChIKey | IFUKBHBISRAZTF-NXIGQQGZSA-M |
| SMILES | Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1.[K+] |
| Potassium 4-[(4-fluorobenzyl)carbamoyl]-1-(2H3)methyl-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}-2-propanyl)-6-oxo-1,6-dihydro-5-pyrimidinolate |
| 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-(methyl-d3)-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-, potassium salt (1:1) |